Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03484130` - Prospective Phenotyping of Autonomous Aldosterone Secretion
Completed	`NCT03718234` - Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia	Phase 1
Completed	`NCT03327142` - EUS-guided FNA in the Study of the Adrenal Gland	N/A

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT03484130 - Prospective Phenotyping of Autonomous Aldosterone Secretion

Completed

NCT03718234 - Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia

Phase 1

Completed

NCT03327142 - EUS-guided FNA in the Study of the Adrenal Gland

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00721929
Study type	Interventional
Source	University of Michigan
Contact
Status	Completed
Phase	N/A
Start date	October 2003
Completion date	July 2012

Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms